Northern Trust’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
Other funds holding TNYA
VCM
EAM
BGM
KCM
Northern Trust's TNYA Position: Q1 2026 in Review
Northern Trust increased its Tenaya Therapeutics (TNYA) stake by 29% in Q1 2026, buying an estimated $51K and bringing the position to 310,654 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.
Northern Trust first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.73M in Q1 2022. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.
- Northern Trust held 310,654 shares of Tenaya Therapeutics worth $215K as of Q1 2026.
- Northern Trust bought 69,074 Tenaya Therapeutics shares in Q1 2026, an estimated $51K.
- Tenaya Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3925 holding.
- Northern Trust first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
- Northern Trust's Tenaya Therapeutics position peaked at $2.73M in Q1 2022.
- 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.